Adam Jacob Schoenfeld MD

PubMed

• Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.
  Pooja Middha, Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cardenas
  Journal for Immunotherapy of Cancer. 2025-03-28
• The Clinical TIL Experience in Melanoma: Past, Present, Future.
  James W Smithy, Adam J Schoenfeld, Allison Betof Warner
  Transplantation and Cellular Therapy. 2025-03-01
• Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy.
  Viswatej Avutu, Jumanah N Algazaq, Kenneth Seier, Rhoena Desir-Camille, Li-Xuan Qin
  Transplantation and Cellular Therapy. 2025-02-22

Journal Articles

• Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients with Metastatic EGFR-Mutant Lung Cancers  
  Helena A Yu, Adam J Schoenfeld, Jamie E Chaft, Gregory J Riely, JAMA Oncology
• Synthesis, Structure, Dynamics, and Selective Methylation of Platinum and Palladium Diphosphametallacyclobutane Complexes  
  Chapp TW, Schoenfeld A, Sanderson MD, Chang C, Glueck DS, Golen J, Moore C, Rheingold A, Organometallics, 2012
• Effects of Linker Length on the Rate and Selectivity of Platinum-Catalyzed Asymmetric Alkylation of the Bis(isitylphosphino)alkanes IsHP(CH2)nPHIs (is = 2,4,6-(i-pr)3C...  
  Chapp TW, Schoenfeld A, Glueck DS, Organometallics, 2010

Abstracts/Posters

• The CNS Germinoma Experience at UCSF from 1980 to 2010
  Schoenfeld A, Molinaro A, Banerjee A, Haas-Kogan D, Mueller S, 3rd International CNS Germ Cell Tumour Symposium, Cambridge, England, 2013

Lectures

• Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers. 
  2019 ASCO Annual Meeting - 6/1/2019